Mesh.i
Exploration
Accueil
Racine
Exploration
Accueil
Racine

Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « Mesh.i » - entrée « Biological Products »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Biological Factors < Biological Products < Biological Therapy  Facettes :

List of bibliographic references indexed by Biological Products

Number of relevant bibliographic references: 255.
[20-40] [0 - 20][0 - 50][40-60]
Ident.Authors (with country if any)Title
000E53 (2019) Thomas Frisell [Suède] ; Johan Askling [Suède]Comment on: Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from the nationwide Swedish register: reply.
000E54 (2019) Hasan Sat ; Gülce Ecem Can [Turquie] ; Reyhan Bilici Salman ; Asl Han Avano Lu Güler ; Hazan Karadeniz ; Abdurrahman TufanComment on: Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from the nationwide Swedish register.
000E55 (2019) Andrew N B. Weil [Royaume-Uni]Comment on: Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from a nationwide Swedish register.
000E92 (2019) Sezgin Sahin [Turquie] ; Duhan Hopurcuoglu [Turquie] ; Sule Bektas [Turquie] ; Ezgi Belhan [Turquie] ; Amra Adrovic [Turquie] ; Kenan Barut [Turquie] ; Nur Canpolat [Turquie] ; Salim Caliskan [Turquie] ; Lale Sever [Turquie] ; Ozgur Kasapcopur [Turquie]Childhood-onset Takayasu arteritis: A 15-year experience from a tertiary referral center.
000F29 (2019) Dimitrios Daoussis [Grèce] ; Georgia Konstantopoulou [Grèce] ; Pantelis Kraniotis [Grèce] ; Lazaros Sakkas ; Stamatis-Nick Liossis [Grèce]Biologics in SAPHO syndrome: A systematic review.
000F31 (2019) Dae Hyun Yoo [Corée du Sud]Biologics for the treatment of adult-onset still's disease.
001075 (2018) E. Diwo [France] ; P. Sève [France] ; S. Trad [France] ; P. Bielefeld [France] ; D. Sène [France] ; S. Abad [France] ; A. Brézin [France] ; P. Quartier [France] ; I. Koné Paut [France] ; M. Weber [France] ; C. Chiquet [France] ; M H Errera [France] ; J. Sellam [France] ; P. Cacoub [France] ; G. Kaplanski [France] ; L. Kodjikian [France] ; B. Bodaghi [France] ; D. Saadoun [France][Therapeutic strategy for the treatment of non-infectious uveitis proposed by an expert panel].
001093 (2018) Tanja A. Stamm [Autriche] ; Berthold Reichardt [Autriche] ; Jochen Zwerina [Autriche] ; Valentin Ritschl [Autriche] ; Valerie Nell-Duxneuner [Autriche]Use of biological disease modifying antirheumatic drugs in rheumatoid arthritis in Austria from 2008 to 2011 : A retrospective analysis of 72% of the population.
001128 (2018) Raimon Sanmartí [Espagne] ; Virginia Ruiz-Esquide [Espagne] ; Carla Bastida [Espagne] ; Dolor Soy [Espagne]Tocilizumab in the treatment of adult rheumatoid arthritis.
001150 (2018) Maria Gerosa [Italie] ; Lorenza Maria Argolini [Italie] ; Carolina Artusi [Italie] ; Cecilia Beatrice Chighizola [Italie]The use of biologics and small molecules in pregnant patients with rheumatic diseases.
001179 (2018) Erin Murray ; Alexandra Ellis ; Yekaterina Butylkova ; Martha Skup [États-Unis] ; Jasmina Kalabic [Allemagne] ; Vishvas Garg [États-Unis]Systematic review and network meta-analysis: effect of biologics on radiographic progression in rheumatoid arthritis.
001198 (2018) Lianne Kearsley-Fleet [Royaume-Uni] ; Michael W. Beresford [Royaume-Uni] ; Rebecca Davies [Royaume-Uni] ; Diederik De Cock [Royaume-Uni] ; Eileen Baildam [Royaume-Uni] ; Helen E. Foster [Royaume-Uni] ; Taunton R. Southwood [Royaume-Uni] ; Wendy Thomson [Royaume-Uni] ; Kimme L. Hyrich [Royaume-Uni]Short-term outcomes in patients with systemic juvenile idiopathic arthritis treated with either tocilizumab or anakinra
001201 (2018) María Martín-L Pez [Espagne] ; Loreto Carmona [Espagne] ; Alejandro Balsa [Espagne] ; Jaime Calvo-Alén [Espagne] ; Raimon Sanmartí [Espagne] ; Jesús Tornero [Espagne] ; José Rosas [Espagne]Serum drug levels of biologic agents in the management of rheumatoid arthritis and spondyloarthritis: a systematic review.
001206 (2018) Andrew I. Rutherford [Royaume-Uni] ; Sujith Subesinghe [Royaume-Uni] ; Kimme L. Hyrich [Royaume-Uni] ; James B. Galloway [Royaume-Uni]Serious infection across biologic-treated patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.
001216 (2018) Sen Wang [République populaire de Chine] ; Qian He [République populaire de Chine] ; Zongwen Shuai [République populaire de Chine]Risk of serious infections in biological treatment of patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a meta-analysis.
001231 (2018) Yoko Shimizu [Japon] ; Eiichi Tanaka [Japon] ; Eisuke Inoue [Japon] ; Kumi Shidara [Japon] ; Naoki Sugimoto [Japon] ; Yohei Seto [Japon] ; Ayako Nakajima [Japon] ; Shigeki Momohara [Japon] ; Atsuo Taniguchi [Japon] ; Hisashi Yamanaka [Japon]Reduction of methotrexate and glucocorticoids use after the introduction of biological disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis in daily practice based on the IORRA cohort.
001235 (2018) F. Iannone [Italie] ; G. Ferraccioli [Italie] ; L. Sinigaglia [Italie] ; E G Favalli [Italie] ; P. Sarzi-Puttini [Italie] ; F. Atzeni [Italie] ; R. Gorla [Italie] ; C. Bazzani [Italie] ; M. Govoni [Italie] ; I. Farina [Italie] ; E. Gremese [Italie] ; A. Carletto [Italie] ; A. Giollo [Italie] ; M. Galeazzi [Italie] ; R. Foti [Italie] ; L. Bianchino [Italie] ; L. La Grasta [Italie] ; G. Lapadula [Italie]Real-world experience of tocilizumab in rheumatoid arthritis: sub-analysis of data from the Italian biologics' register GISEA.
001254 (2018) Eva-Maria Didden [Suisse] ; Yann Ruffieux [Suisse] ; Noemi Hummel [Suisse] ; Orestis Efthimiou [Suisse] ; Stephan Reichenbach [Suisse] ; Sandro Gsteiger [Suisse] ; Axel Finckh [Suisse] ; Christine Fletcher [Royaume-Uni] ; Georgia Salanti [Suisse] ; Matthias Egger [Suisse]Prediction of Real-World Drug Effectiveness Prelaunch: Case Study in Rheumatoid Arthritis.
001264 (2018) Thomas Frisell [Suède] ; Eva Baecklund [Suède] ; Karin Bengtsson [Suède] ; Daniela Di Giuseppe [Suède] ; Helena Forsblad-D'Elia [Suède] ; Johan Askling [Suède]Patient characteristics influence the choice of biological drug in RA, and will make non-TNFi biologics appear more harmful than TNFi biologics.
001274 (2018) Lillian Barra [Canada] ; Grace Yang [Canada] ; Christian Pagnoux [Canada]Non-glucocorticoid drugs for the treatment of Takayasu's arteritis: A systematic review and meta-analysis.
001277 (2018) Seoyoung C. Kim [États-Unis] ; Daniel H. Solomon [États-Unis] ; James R. Rogers [États-Unis] ; Sara Gale [États-Unis] ; Micki Klearman [États-Unis] ; Khaled Sarsour [États-Unis] ; Sebastian Schneeweiss [États-Unis]No difference in cardiovascular risk of tocilizumab versus abatacept for rheumatoid arthritis: A multi-database cohort study.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Biological Products" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Biological Products" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Biological Products
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021